Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1006179511178
Reference40 articles.
1. Powles TJ, Hickish TF, Makris A, Ashley SE, O'Brien MER, Tidy VA, Casey S, Nash AG, Sacks N, Cosgrove D, et al.: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13: 547–552, 1995
2. Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bartoli C, Coopmans de Yoldi G, Zucali R, Rilke F, et al.: Primary chemotherapy to avoid mastectomy in tumors with diameter of three centimeters or more. J Natl Cancer Inst 82: 1539–1545, 1990
3. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, Mc-Neese MD, Paulus D, Hug V, Holmes FA, Romsdahl MM, Fraschini G, et al.: Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62: 2507–2516, 1988
4. Scholl SM, Pierga JY, Asselain B, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Palangie T, Remvikos Y, Durand JC, et al.: Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 31A(12): 1969–1975, 1996
5. Anderson EDC, Forrest APM, Levack PA, Chetty U, Hawkins RA: Response to endocrine manipulation and oestrogen receptor concentration in large operable breast cancer. Br J Cancer 60: 223, 1989
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers;Breast Cancer Research and Treatment;2022-02-28
2. Effects of Neoadjuvant Chemotherapy on Hormone Receptor Expression in Breast Cancer;Advances in Clinical Medicine;2022
3. HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation;Journal of Pathology and Translational Medicine;2020-01-15
4. Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer;Technology in Cancer Research & Treatment;2020-01-01
5. Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy;Cancer Chemotherapy and Pharmacology;2019-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3